The authors describe a proprietary process for producing a stable, topical interferon alpha-2b formulation that can deliver large drug molecules into the skin or mucosa.
Jinghui Shen
Advertisement
Jinghui Shen, B. Eng., is an analytical chemist at Helix BioPharma.
Articles by Jinghui Shen
Advertisement
Latest Updated Articles
Stabilization of Interferon alpha-2b in a Topical CreamPublished: July 2nd 2009 | Updated:
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Clearing Hurdles in Sustainability, AI, and CDMO Partnerships
2
Drug Digest: Strategic Alliances and Technology Integration in the Evolving Biopharma Landscape
3
PharmTech Weekly News Roundup — Week of October 27, 2025
4
Dosage Form Innovations: A CPHI Frankfurt Conversation with Lonza’s Frank Romanski, Part One
5
